NU
Nuwellis, Inc.
NUWE · NASDAQ
$0.83 -3.81% (-$0.03)
1M -21.30%
Market Cap $76.2K
P/E Ratio -
Div. Yield -
ROE 605.75%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
12 /100
Declining Rev. growth 1.08%
Book val. growth 40.34%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 69.69%
Net margin 123.38%
Op. margin 140.62%
Quality
12 /100
Poor ROIC 238.77%
ROE 605.75%
ROA 121.85%
Debt
99 /100
Low Current ratio 1.97x
Debt/Equity N/A
Int. coverage N/A
Stability
36 /100
Moderate Beta 0.29x
Rev. volatility 4.58%
EPS volatility 179.11%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NUWE
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael McCormick
Employees
38
Headquarters
Eden Prairie
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report